Cardioselective anti-ischemic ATP-sensitive potassium channel openers.
Atwal
K S
KS
Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000.
Grover
G J
GJ
Ahmed
S Z
SZ
Ferrara
F N
FN
Harper
T W
TW
Kim
K S
KS
Sleph
P G
PG
Dzwonczyk
S
S
Russell
A D
AD
Moreland
S
S
D000255:Adenosine Triphosphate / Q000494:pharmacology*; D000818:Animals; D001011:Aorta / Q000187:drug effects / Q000502:physiology; D001578:Benzopyrans / Q000737:chemistry* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use; D001682:Biological Availability; D003042:Cocaine / Q000031:analogs & derivatives* / Q000138:chemical synthesis / Q000378:metabolism / Q000494:pharmacology; D019806:Cromakalim; D006146:Guanidines / Q000737:chemistry* / Q000493:pharmacokinetics / Q000627:therapeutic use; D015640:Ion Channel Gating / Q000187:drug effects*; D015394:Molecular Structure; D017202:Myocardial Ischemia / Q000188:drug therapy*; D015221:Potassium Channels / Q000187:drug effects / Q000502:physiology*; D011758:Pyrroles / Q000494:pharmacology; D051381:Rats; D013329:Structure-Activity Relationship; D014664:Vasodilation / Q000187:drug effects
D001578:Benzopyrans; D006146:Guanidines; D015221:Potassium Channels; D011758:Pyrroles; D019806:Cromakalim; C084740:methyl 3-benzoyloxy-7-methoxy-8-methyl-8-azabicyclo(3.2.1)octane-2-carboxylate; D000255:Adenosine Triphosphate; C084684:BMS 180448; D003042:Cocaine